Search

TransMedics Group Inc

Cerrado

SectorSanidad

86.43 -1.41

Resumen

Variación precio

24h

Actual

Mínimo

84.43

Máximo

87.76

Métricas clave

By Trading Economics

Ingresos

7.4M

15M

Ventas

16M

190M

P/B

Media del Sector

23.311

56.597

BPA

0.44

Margen de beneficios

7.729

Empleados

898

EBITDA

-889K

27M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+5.48% upside

Dividendos

By Acuity

Próximas Ganancias

28 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

302M

3.1B

Apertura anterior

87.84

Cierre anterior

86.43

Noticias sobre sentimiento de mercado

By Acuity

82%

18%

317 / 339 Clasificación en Healthcare

TransMedics Group Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

9 sept 2026, 20:07 UTC

Social Media

Transmedics Group Inc shares are lower today, breaking a recent trend despite positive sentiment reported by Jefferies' Transplant Tracker earlier this month.

8 sept 2026, 19:56 UTC

News
Social Media

Transmedics Group reported EPS of $0.44 but lowered its adjusted operating margin guidance, contributing to a decline in shares since Friday's close.

4 sept 2026, 20:07 UTC

News

Transmedics Group reported Q2 EPS of $0.44, missing estimates. The company raised its 2026 revenue outlook, boosting investor sentiment and shares during Friday's session.

2 sept 2026, 19:56 UTC

Transmedics Group Inc shares are trading higher today, reflecting notable intraday volatility amid rising U.S. Treasury yields and broader market fluctuations.

1 sept 2026, 20:09 UTC

Transmedics Group Inc shares declined during Tuesday's session, reaching a low before a slight recovery. The stock remains below its 20-day moving average.

31 ago 2026, 20:03 UTC

Transmedics Group Inc shares are declining amid broader economic concerns following remarks from Warsh at the Jackson Hole Economic Symposium.

28 ago 2026, 20:07 UTC

Transmedics Group Inc shares are lower today, continuing a downward trend amid rising U.S. Treasury yields and no specific company news identified.

27 ago 2026, 19:16 UTC

Transmedics Group Inc. shares are lower amid broader market concerns about persistent U.S. inflation, despite a brief midday rebound earlier in the session.

26 ago 2026, 21:36 UTC

Transmedics Group Inc. shares declined slightly in after-market trading, reflecting broader market caution ahead of Nvidia's earnings report and recent inflation data.

25 ago 2026, 19:46 UTC

TransMedics Group Inc is trading lower today, with no specific news identified. The stock remains near its one-month range's upper end.

24 ago 2026, 23:06 UTC

TransMedics Group Inc shares are lower in after-market hours, reflecting a decline since Monday's close. Broader market concerns about the U.S.-Iran conflict persist.

21 ago 2026, 19:36 UTC

Transmedics Group Inc shares are higher, maintaining an upward trend since Thursday's close despite a pullback from earlier session highs. No specific news identified.

20 ago 2026, 19:46 UTC

Transmedics Group Inc is trading lower today, following an early drop that set the day's low. No specific news was identified for the decline.

19 ago 2026, 23:11 UTC

Transmedics Group Inc is trading lower in after-market hours, having retraced from a brief peak earlier in the session amid routine price activity.

18 ago 2026, 19:16 UTC

Social Media

Transmedics Group plans to accelerate revenue growth, projecting $757 million by 2026. Shares are higher today, rebounding from earlier session lows.

13 ago 2026, 19:52 UTC

Transmedics Group Inc shares are trading higher, recovering from an earlier low. The stock remains above its 20-day moving average amid strong sector interest.

12 ago 2026, 19:36 UTC

Transmedics Group Inc shares are lower during Wednesday's session amid unusual volatility. The stock remains above its 20-day moving average despite the decline.

11 ago 2026, 19:16 UTC

Transmedics Group Inc. shares are lower today, pulling back from an earlier session high. The stock remains above its 20-day moving average.

10 ago 2026, 19:21 UTC

Social Media

Transmedics Group Inc is rising amid a broader rally in Health Care Equipment. Positive market sentiment and strong performance metrics are driving interest in the stock.

7 ago 2026, 19:22 UTC

News

TransMedics shares are higher as Piper Sandler and Needham adjust price targets, reflecting positive sentiment from multiple analysts during Friday's trading session.

6 ago 2026, 20:03 UTC

Social Media
News

Transmedics Group Inc shares are higher, supported by positive Q2 results and mentions in a fund manager's portfolio, despite potential short-term volatility concerns.

5 ago 2026, 20:03 UTC

Social Media
News

TransMedics Group Inc. shares are lower following mixed quarterly results and an earnings miss, prompting price target cuts from Piper Sandler and UBS.

4 ago 2026, 23:02 UTC

News
Social Media

Transmedics Group shares are lower in after-market hours following Q2 results, where adjusted EPS of $0.44 missed expectations despite revenue surpassing estimates.

3 ago 2026, 19:51 UTC

Social Media
News

TransMedics Group Inc. shares are rising, despite an analyst downgrade to a $106 price target from $142, amid positive social media discussions.

30 jul 2026, 19:03 UTC

Transmedics Group Inc shares are lower during Thursday's session, with no specific news identified. Broader market uncertainty may be influencing the decline.

29 jul 2026, 23:36 UTC

Transmedics Group Inc. shares are lower in after-market trading, reflecting broader market volatility amid rising interest rates and geopolitical tensions.

28 jul 2026, 19:46 UTC

Transmedics Group Inc shares are higher today, advancing since Monday. The stock peaked earlier but pulled back from a session high.

27 jul 2026, 15:16 UTC

Social Media
News

Transmedics Group Inc is higher today amid social media discussions on its undervaluation and expectations for significant profit by 2028.

24 jul 2026, 20:02 UTC

Social Media

Transmedics Group Inc gains amid positive feedback from Jefferies on its technology and growth prospects, aligning with strength in the Health Care Equipment sector.

22 jul 2026, 19:46 UTC

Transmedics Group Inc shares are lower today, reflecting ongoing declines. The stock's volatility coincides with rising crude oil prices amid geopolitical tensions.

Comparación entre iguales

Cambio de precio

TransMedics Group Inc previsión

Precio Objetivo

By TipRanks

5.48% repunte

Estimación a 12 Meses

Media 93.11 USD  5.48%

Máximo 122 USD

Mínimo 65 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para TransMedics Group Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

7

Comprar

4

Mantener

0

Vender

Sentimiento

By Acuity

317 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
help-icon Live chat